We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
+8.52%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$437M
AUM Growth
+$26.5M
Cap. Flow
-$5.57M
Cap. Flow %
-1.28%
Top 10 Hldgs %
65.65%
Holding
157
New
10
Increased
71
Reduced
61
Closed
4

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$452K
2
LLY icon
Eli Lilly
LLY
+$427K
3
DE icon
Deere & Co
DE
+$309K
4
CNC icon
Centene
CNC
+$266K
5
MOS icon
The Mosaic Company
MOS
+$248K

Sector Composition

Rank Sector Weight
1 Technology 13.01%
2 Healthcare 12.95%
3 Consumer Staples 4.69%
4 Communication Services 2.94%
5 Financials 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$153B
$2.42M 0.55%
94,931
-5,340
-5% -$132K
ABT icon
27
Abbott
ABT
$187B
$2.41M 0.55%
17,989
+1,181
+7% +$155K
MRK icon
28
Merck
MRK
$318B
$2.19M 0.5%
26,067
-1,604
-6% -$132K
GEHC icon
29
GE HealthCare
GEHC
$32.4B
$2.18M 0.5%
29,081
+1,072
+4% +$80K
BDX icon
30
Becton Dickinson
BDX
$48.2B
$2.16M 0.5%
11,555
-834
-7% -$155K
MOS icon
31
The Mosaic Company
MOS
$7.33B
$2.11M 0.48%
60,946
+7,189
+13% +$248K
SYK icon
32
Stryker
SYK
$130B
$1.95M 0.45%
5,281
+380
+8% +$147K
TMO icon
33
Thermo Fisher Scientific
TMO
$220B
$1.85M 0.42%
3,812
-537
-12% -$250K
LH icon
34
Labcorp
LH
$25.9B
$1.65M 0.38%
5,744
-212
-4% -$56.8K
CVS icon
35
CVS Health
CVS
$122B
$1.62M 0.37%
21,439
-1,314
-6% -$90.1K
AMGN icon
36
Amgen
AMGN
$222B
$1.61M 0.37%
5,690
-215
-4% -$62.4K
CTVA icon
37
Corteva
CTVA
$51.3B
$1.53M 0.35%
22,662
+105
+0.5% +$7.61K
BAX icon
38
Baxter International
BAX
$14.2B
$1.51M 0.35%
66,530
+17,822
+37% +$452K
BMY icon
39
Bristol-Myers Squibb
BMY
$132B
$1.48M 0.34%
32,853
+247
+0.8% +$11.5K
UNH icon
40
UnitedHealth
UNH
$370B
$1.46M 0.33%
4,215
-184
-4% -$55.6K
GILD icon
41
Gilead Sciences
GILD
$165B
$1.42M 0.32%
12,757
-1,393
-10% -$158K
VZ icon
42
Verizon
VZ
$196B
$1.39M 0.32%
31,655
+1,180
+4% +$51.1K
BSX icon
43
Boston Scientific
BSX
$71.5B
$1.3M 0.3%
13,328
+968
+8% +$100K
T icon
44
AT&T
T
$163B
$1.26M 0.29%
44,526
-28
-0.1% -$795
DGX icon
45
Quest Diagnostics
DGX
$26.3B
$1.23M 0.28%
6,452
+233
+4% +$41.3K
DELL icon
46
Dell
DELL
$293B
$1.23M 0.28%
8,647
-1,378
-14% -$179K
AMZN icon
47
Amazon
AMZN
$2.96T
$1.23M 0.28%
5,582
-379
-6% -$85.8K
HCA icon
48
HCA Healthcare
HCA
$89.5B
$1.2M 0.28%
2,819
+95
+3% +$36.8K
CL icon
49
Colgate-Palmolive
CL
$74.4B
$1.16M 0.26%
14,458
+1,570
+12% +$134K
VRTX icon
50
Vertex Pharmaceuticals
VRTX
$126B
$1.12M 0.26%
2,864
+375
+15% +$157K

Similar funds

Humankind Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Humankind Investments held 157 positions worth $437M, up 6.5% from $410M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Humankind Investments's Q3 2025 filing shows 10 new, 71 increased, 61 reduced and 4 closed positions. Its largest new stake was Enphase Energy: 6,126 shares worth $217K. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $3.66M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Humankind Investments's largest Q3 2025 buy was Enphase Energy: 6,126 shares worth $217K.
  • Humankind Investments added most to Baxter International in Q3 2025, an estimated $452K increase.
  • Humankind Investments's biggest Q3 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $3.66M.
  • Humankind Investments fully exited Walgreens Boots Alliance in Q3 2025, selling an estimated $1.06M.
  • Humankind Investments's ten largest holdings make up 66% of its $437M portfolio in Q3 2025.
  • Humankind Investments opened 10 new positions and closed 4 in Q3 2025.
  • Humankind Investments's portfolio value rose 6.5% quarter-over-quarter to $437M.

Based on Humankind Investments's 13F filing for Q3 2025, filed 14 Nov 2025.